NCT04699838 2026-01-02Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung CancerBig Ten Cancer Research ConsortiumPhase 2 Recruiting30 enrolled